The Saarbrücker Zeitung presents the Pharma Campus

August 29, 2022General

The Saarbrücker Zeitung reports on the Schiffweiler site In its edition of August 24, 2022, the Saarbrücker Zeitung reports in the business section of the Neunkirch edition on the Schiffweiler site and our three companies Europharm, 1azPharm and TempTrans: Huge pharmaceutical campus being built in Schiffweiler. In Schiffweiler, a group of companies from the pharmaceutical industry is on course for major growth. In addition to trading in medicines ... Read More

Staff support: More advice on clinical trial studies

15 December 2021General

Our customers always ask for safe information about our products. Clinical trial studies are part of this. To be able to offer our contacts a higher quality of advice, we have added Malgorzata Wolska to our team. She comes from Warsaw, Poland, studied management at the University of the Humanities and Economics in Lodz and later acquired her expertise at the University of ... Read More

New in the portfolio: Smoking cessation products

8 December 2021General

Recently, smoking cessation products have also been stocked and distributed by 1azPharm. The drug based on the active ingredient cytisine by the manufacturer Aflofarm is intended for smokers who are willing to quit smoking. Cytisine acts on receptors that are responsible for nicotine dependence.

New hall: 1azPharm builds up more capacity

25 November 2021General

A new warehouse is currently being built on the 1azPharm site. This will expand our capacities and enable us to respond even faster and more flexibly to the needs of our customers. The new hall has a floor space of 3000 square metres and a height of 12 metres. A cold store with 1000 square metres of space will be integrated into it. In addition, there will be docking stations ... Read More

Supply optimised: Cooperation on medical cannabis

11 November 2021General

More and more patients are discovering medicinal cannabis for themselves, and more and more doctors are seeing sensible cases for the use of cannabis as a medicine. Through a new cooperation, 1azPharm has now created the basis for being able to react appropriately to an increasing demand.